In the final episode of KDIGO’s three-part Conversations in Nephrology series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Titilayo Ilori, MD (Boston University, United States), and kidney health advocate Joshua Albright (United States) about how APOL1 genetic testing can shape the future of kidney care. Their conversation brings together clinical expertise and lived experience to examine why early detection matters, how to overcome barriers to equitable testing, and what it will take to turn awareness into meaningful action for patients and communities.

Learn more and access resources from the KDIGO Controversies Conference on APOL1 Kidney Disease: https://kdigo.org/conferences/apol1-kidney-disease/


This podcast was supported by Vertex Pharmaceuticals.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör KDIGO Communications. Innehållet i podden är skapat av KDIGO Communications och inte av, eller tillsammans med, Poddtoppen.